$EXFY

Alvarez Divo Carlos Eduardo sold $11K of EXFY

Alvarez Divo Carlos Eduardo sold 10,000 shares of Expensify, Inc. (EXFY) at $1.13 on 2026-05-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Alvarez Divo Carlos Eduardo
Published May 28, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:48 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$EXFY
Neutral
medium confidence
Mentioned
$EXFY
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EXFYNeutralLow
01

Why it matters

The disclosure provides transparency on insider selling activity but does not include any new corporate event (earnings, guidance, deal, or investigation).

02

Market read

Traders may monitor insider activity for sentiment, but this specific filing is unlikely to drive a fundamental repricing on its own.

03

What to watch

10b5-1 plans can be triggered regardless of company outlook; without context on prior sales, the market may over-interpret the disclosure.

Relevance 2/10Novelty 3/10Timing: Form 4 filed May 28, covering a sale dated May 15.

Background

The article is an SEC Form 4 insider transaction disclosure for Expensify, Inc.

Company-level read

Ticker impact

$EXFYNeutralMedium confidence
Context

Expensify director Alvarez Divo sold 10,000 shares in an open-market transaction at $1.13 on a 10b5-1 plan, per Form 4 filed May 28.

Expected impact

Likely minimal, unless the market interprets the sale as unusual relative to prior insider activity.

Evidence & confidence

The filing discloses transaction size and price, but it is explicitly tied to a pre-arranged 10b5-1 plan and provides no new company-specific operational or financial information.

Market effects

No clear sector read-through from a single director 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

If this sale is larger or more frequent than prior director activity, traders could treat it as a mild negative sentiment input despite the 10b5-1 label.

Key entities

  • Expensify, Inc.

    Subject of the Form 4 insider transaction disclosure (EXFY).

  • Alvarez Divo Carlos Eduardo

    Director who executed an open-market sale under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$EXFYMedAI 9/10

Expensify (EXFY) Q2 2026 Earnings Call Transcript

Expensify (EXFY) reported Q2 2026 revenue of $33.9M, down 5% year over year, with paid members at 640,000, down 2%. Interchange revenue rose 12% to $5.9M. Free cash flow guidance for fiscal 2026 was raised to $12M to $14M. The company also repurchased 6.8M shares and said new revenue comes from the New Expensify platform.

Med

Expensify: New Platform Revenue Surges Over 250% As AI Agents Connect With ChatGPT, Claude And Cursor

Expensify reported New Expensify net-new customer revenue rose more than 250% year over year to over $10 million in annual recurring revenue, exceeding 10,000 new accounts. Overall quarterly revenue fell 5% to $33.9 million. Expensify launched Expensify MCP connecting to ChatGPT, Claude and Cursor. Interchange revenue rose 12% to $5.9 million; free cash flow was $6.4 million. Expensify repurchased ~6.8M Class A shares.

$EXFYMed

Expensify Reports Q2 2026 Results, Highlights New Platform

Expensify (EXFY) reported Q2 2026 results on Aug. 6. Net revenue fell 5% Y/Y to $33.9M. Net loss narrowed to $3.9M, while non-GAAP net income was $3.4M. Operating cash was $8.4M and free cash flow $6.4M. Interchange revenue rose 12% to $5.9M. The company repurchased 6.8M Class A shares and said annual recurring revenue from New Expensify exceeded $10M.

$EXFYMed

Citizens upgrades Expensify stock rating on growth outlook

Citizens upgraded Expensify Inc (NASDAQ:EXFY) to Market Outperform from Market Perform and set a $3.00 price target. The firm cited expectations for a return to growth after 13 quarters of contraction, plus Q2 2026 metrics including over $10M New Expensify ARR and 45,700 paid companies. Expensify reported $33.9M revenue, -$0.04 adjusted EPS, and raised its free cash flow outlook.

$EXFYHighAI 9/10

Expensify Inc (EXFY) (Q2 2026) Earnings Call Highlights: AI-Driven New Expensify Surges 250%

Expensify’s Q2 2026 earnings call said new Expensify ARR rose from about $7M at end of Q1 to about $12M at end of Q2, growing over 250% year over year. The company said over 56% of users are on new Expensify and virtually all incremental revenue comes from it. Full-year 2026 free cash flow guidance was raised to $12M-$14M. Q2 revenue was $33.9M and FCF $6.4M.